• S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

  • Mar 30 2021
  • Duración: 24 m
  • Podcast

S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles